<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vsp</journal-id><journal-title-group><journal-title xml:lang="ru">Вопросы современной педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Current Pediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-5527</issn><issn pub-type="epub">1682-5535</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/vsp.v13i1.929</article-id><article-id custom-type="elpub" pub-id-type="custom">vsp-244</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SHORT REPORTS</subject></subj-group></article-categories><title-group><article-title>ОПЫТ ИСПОЛЬЗОВАНИЯ УВЛАЖНЯЮЩЕГО ЛОСЬОНА, СПЕЦИАЛЬНО РАЗРАБОТАННОГО ДЛЯ АТОПИЧНОЙ КОЖИ</article-title><trans-title-group xml:lang="en"><trans-title>EXPERIENCE OF USE OF SPECIAL MOISTENING LOTION IN ATOPIC DERMATITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бирюкова</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Biryukova</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Birjukova Elena Gennad’evna, MD, senior research assistant of Department of Innovative Researche Approaches of Peculiarities of Child Development and Outpatient Health Monitoring, RAMS Address: Lomonosovskij prospekt, 2, building 1, Moscow, Russian Federation, 119991, Tel.: (499) 783-27-93, e-mail: birukova@nczd.ru</p></bio><email xlink:type="simple">birukova@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ефимова</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Efimova</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">birukova@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Варфоломеева</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Varfolomeeva</surname><given-names>E. Yu.</given-names></name></name-alternatives><email xlink:type="simple">birukova@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федоровская</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorovskaya</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">birukova@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аствацатурова</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Astvatsaturova</surname><given-names>M. Yu.</given-names></name></name-alternatives><email xlink:type="simple">birukova@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Висарова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Visarova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">birukova@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савватеева</surname><given-names>Н. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Savvateeva</surname><given-names>N. Yu.</given-names></name></name-alternatives><email xlink:type="simple">birukova@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научный центр здоровья детей, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Centre of Children Health, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>11</day><month>01</month><year>2014</year></pub-date><volume>13</volume><issue>1</issue><issue-title>Вопросы современной педиатрии</issue-title><fpage>167</fpage><lpage>171</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бирюкова Е.Г., Ефимова С.А., Варфоломеева Е.Ю., Федоровская Н.А., Аствацатурова М.Ю., Висарова Н.В., Савватеева Н.Ю., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Бирюкова Е.Г., Ефимова С.А., Варфоломеева Е.Ю., Федоровская Н.А., Аствацатурова М.Ю., Висарова Н.В., Савватеева Н.Ю.</copyright-holder><copyright-holder xml:lang="en">Biryukova E.G., Efimova S.A., Varfolomeeva E.Y., Fedorovskaya N.A., Astvatsaturova M.Y., Visarova N.V., Savvateeva N.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vsp.spr-journal.ru/jour/article/view/244">https://vsp.spr-journal.ru/jour/article/view/244</self-uri><abstract><p>Цель исследования: оценить безопасность увлажняющего лосьона при атопическом дерматите у детей и их восприятие базового ухода за кожей данным средством. Пациенты и методы: в исследовании приняли участие 466 детей в возрасте от 14 сут жизни до 18 лет, из них 222 (48%) девочки и 244 (52%) мальчика; 271 (58,2%) ребенок был предрасположен к аллергическим проявлениям, у 158 (33,9%) человек диагностирован атопический дерматит. Проведен опрос всех пациентов и их родителей по специально разработанной анкете, в которой отражены основные субъективные ощущения больных (жжение кожи, сухость кожи, гиперемия). Оценку производили по трехбалльной системе (0–2 балла). Результаты: при оценке субъективных ощущений после использования лосьона в общей группе детей отсутствие жжения кожи отмечено у 443 (95,5%), сухости кожи — у 448 (96,1%) и гиперемии — у 457 (98,1%) детей. При оценке анкет детей с атопическим дерматитом отсутствие жжения кожи отмечено у 151 (95,6%), сухости кожи — у 152 (96,2%) и гиперемии — у 155 (98,1%) пациентов. Кроме того, средство продемонстрировало высокую косметическую приемлемость в обеих исследуемых группах. Выводы: показана высокая безопасность и косметическая приемлемость увлажняющего лосьона и в общей группе детей, и у пациентов с атопическим дерматитом.</p></abstract><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>атопический дерматит</kwd><kwd>аллергические проявления</kwd><kwd>базовый уход за кожей</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>atopic dermatitis</kwd><kwd>allergic reactions</kwd><kwd>basis skin care</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Namazova-Baranova L. S. Allergija u detej: ot teorii — k praktike. Monografija. Serija “Sovremennaja pediatrija: ot teorii — k praktike” [Child allergy: bedside approach. Study. Line “Current pediatrics: bedside approach”]. Edited by L. S. Namazova-Baranova. Moscow, Sojuz pediatrov Rossii, 2010–2011. 668 p.</mixed-citation><mixed-citation xml:lang="en">Namazova-Baranova L. S. Allergija u detej: ot teorii — k praktike. Monografija. Serija “Sovremennaja pediatrija: ot teorii — k praktike” [Child allergy: bedside approach. Study. Line “Current pediatrics: bedside approach”]. Edited by L. S. Namazova-Baranova. Moscow, Sojuz pediatrov Rossii, 2010–2011. 668 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ogorodova L. M., Namazova-Baranova L. S., Smirnova G. I. Atopicheskij dermatit. V kn.: Pediatrija. Nac. ruk-vo. Kratk. izd. [Atopic dermatitis. Included in book: Pediatrics. National guidance. Shortened edition]. Edited by A. A. Baranov. Moscow, GJeOTARMedia, 2013. pp. 495–513.</mixed-citation><mixed-citation xml:lang="en">Ogorodova L. M., Namazova-Baranova L. S., Smirnova G. I. Atopicheskij dermatit. V kn.: Pediatrija. Nac. ruk-vo. Kratk. izd. [Atopic dermatitis. Included in book: Pediatrics. National guidance. Shortened edition]. Edited by A. A. Baranov. Moscow, GJeOTARMedia, 2013. pp. 495–513.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ellis C., Luger T., Abeck D. et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Brit. J. Dermatol. 2003; 148 (Suppl. 63): 3–10.</mixed-citation><mixed-citation xml:lang="en">Ellis C., Luger T., Abeck D. et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Brit. J. Dermatol. 2003; 148 (Suppl. 63): 3–10.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Simpson E. L. Atopic dermatitis: а review of topical treatment options. Curr. Med. Res. Opin. 2010; 26 (3): 633–640.</mixed-citation><mixed-citation xml:lang="en">Simpson E. L. Atopic dermatitis: а review of topical treatment options. Curr. Med. Res. Opin. 2010; 26 (3): 633–640.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Smethurs D., Macfarlane S. Atopic eczema. Clin. Evid. 2002; 1785–1803.</mixed-citation><mixed-citation xml:lang="en">Smethurs D., Macfarlane S. Atopic eczema. Clin. Evid. 2002; 1785–1803.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Leung D. Y. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. Allergy Clin. Immunol. 2009; 124: 494–495.</mixed-citation><mixed-citation xml:lang="en">Leung D. Y. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. Allergy Clin. Immunol. 2009; 124: 494–495.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Barker J. N. et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. Invest. Dermatol. 2007; 127: 504–507.</mixed-citation><mixed-citation xml:lang="en">Barker J. N. et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. Invest. Dermatol. 2007; 127: 504–507.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Simpson E. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J. Dermatol. Treat. 2013; 24: 122–125.</mixed-citation><mixed-citation xml:lang="en">Simpson E. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J. Dermatol. Treat. 2013; 24: 122–125.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Simpson E., Dutronc Y. A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults. J. Drugs Dermatol. 2011; 10: 744–749.</mixed-citation><mixed-citation xml:lang="en">Simpson E., Dutronc Y. A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults. J. Drugs Dermatol. 2011; 10: 744–749.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
